Category: failure to disclose COI

Troubled article ranking business schools earns expression of concern

jpimAn article that ranked University of Missouri-Kansas City number one in an area of business school training is set to receive an expression of concern. The move follows months of questions over the ranking’s legitimacy, following revelations such as a relationship between the authors and both the school and its top ranked researcher in the field.

In 2011, the business world got a bit of a surprise: In the field of innovation management, the study of how entrepreneurs convert good ideas into profit, the number one school – according to an article in the Journal of Product Innovation Management — was UMKC. Not Harvard, not Stanford, not any other institution that normally tops these types of rankings. UMKC’s Henry W. Bloch School of Management was also home to the number one researcher in that field, Michael Song.

The school, of course, was elated, immediately issuing a press release titled “UMKC Ranked No. 1 in the World.”

But after publication, a UMKC professor raised concerns about the paper’s methodology. An investigation by the Kansas City Star uncovered some issues:

Continue reading Troubled article ranking business schools earns expression of concern

Conflict of interest, figure issues net retraction for cancer paper

am j pathologyTwo major problems sunk this cancer paper.

For one, many of the images were copied from another paper. In addition, one of the authors did not disclose that he was the president of a related company, nor that his company provided reagents for the experiments.

It’s not clear when the paper was published, but The paper was published on October 16, 2014, and a withdrawal notice went up on January 16, 2015. Here’s the retraction for “Enhanced Detection and Phenotypic and Karyotypic in Situ Characterization of Circulating Tumor Cells”: Continue reading Conflict of interest, figure issues net retraction for cancer paper

Can’t spell Novartis without VART: Drug study retracted for conflict of interest, data issues

JHH(Cover).inddA major scandal in Japan over the Novartis hypertension drug valsartan has resulted in a retraction from the Journal of Human Hypertension. 

Frequent Retraction Watch subject Hiroaki Matsubara resigned his post at Kyoto Prefectural University in 2013, after his work on valsartan was shown to be riddled with data errors and undisclosed conflicts of interest.

Also that year, suspicions about Chiba University hypertension researcher Issei Komuro’s work were first raised by an anonymous blog, which detailed numerous image manipulations in the researcher’s published works. Komuro, who frequently collaborated with Matsubara, has been a senior author on a number of valsartan papers, including the now-retracted one, which reported the results of Novartis-sponsored Valsartan Amlodipine Randomized Trial in 2011 without reporting the Novartis funding.

The paper, which has been cited three times, according to Thomson Scientific’s Web of Knowledge, had already been subject to a correction in 2013:  Continue reading Can’t spell Novartis without VART: Drug study retracted for conflict of interest, data issues

Controversial editor and patient safety expert had undisclosed COIs in 9 of 10 papers

denham
Charles Denham

A new editorial in the Journal of Patient Safety accuses former editor and patient safety expert Charles Denham of having undeclared conflicts of interest in nine out of ten articles he published in the journal.

Denham was at the center of massive controversy earlier this year, when the government accused him of taking more than $11 million in kickbacks from medical supply company CareFusion. Supposedly, he took the money to influence the National Quality Forum, where Denham was a co-chair of safe practices, to endorce ChloraPrep, a CareFusion antiseptic.

Cheryl Clark, at HealthLeaders Media, was first to report on the new editorial. Here’s what the editors wrote: Continue reading Controversial editor and patient safety expert had undisclosed COIs in 9 of 10 papers

“Undeclared competing interest” sinks fish oil takedown by author fined for deceptive claims

Snake swallowing a whole fish
Image via Jesse Palmer

The Journal of Lipids has retracted an aggressively negative review article called “Why Fish Oil Fails,” written by one Brian S. Peskin, whose bogus health claims have landed him in plenty of hot water in the past.

Here’s the notice: Continue reading “Undeclared competing interest” sinks fish oil takedown by author fined for deceptive claims

Failure to disclose drug company sponsor among litany of reasons for cancer retraction

tumor biologyThis one’s a real mess.

In June, a paper in Tumor Biology was retracted for at least four reasons, including bad data and hiding a trial sponsor (Merck). Some people who contributed work weren’t cited; at least one author had no idea his name would be on it. And that’s just what they tell us in the notice.

Here’s the notice for “Neutropenia and invasive fungal infection in patients with hematological malignancies treated with chemotherapy: a multicenter, prospective, non-interventional study in China:” Continue reading Failure to disclose drug company sponsor among litany of reasons for cancer retraction

Journal makes it official, retracting controversial autism-vaccine paper

translational neurodegenerationA little more than a month after removing a highly criticized article that claimed the measles-mumps-rubella (MMR) vaccine increased the risk of autism in African American boys, Translational Neurodegeneration has officially retracted the paper.

Here’s the notice, dated yesterday: Continue reading Journal makes it official, retracting controversial autism-vaccine paper

“Personal rivalry” leads to retraction of nut-health paper

ejpcHere’s a retraction that leaves us itching to know more:

The authors of a recent paper in the European Journal of Preventive Cardiology on nut intake and the risk of high blood pressure and diabetes have pulled their article from publication for an undisclosed conflict of interest.

Now, you wouldn’t know this unless you were willing to pony up the $32 to read the notice, which is behind a pay wall — something that drives us, well, nuts. But here it is:

Continue reading “Personal rivalry” leads to retraction of nut-health paper

Lack of conflict of interest disclosure undoes scoliosis study

scoliosisThe journal Scoliosis has retracted a 2012 paper by a pair of German spine doctors over what the editors have called a less-than-fully declared conflict of interest involving one of the authors.

That should be relatively straigtforward – but it’s not quite. Turns out the article does include a disclosure, although perhaps the information it contains was incomplete.

The article, “Soft braces in the treatment of Adolescent Idiopathic Scoliosis (AIS) – Review of the literature and description of a new approach,” was written by Hans-Rudolf Weiss and Mario Werkmenn. Weiss, it seems, has something of a pedigree in the field. According to this website, he practices the “Schroth method” of recurvature, a technique pioneered by his grandmother, Katharina Schroth. From the site: Continue reading Lack of conflict of interest disclosure undoes scoliosis study

Flawed disclosure leads dental journal to retract disinfection paper

The Journal of the American Dental Association has retracted a paper it published earlier this year after learning that the author took liberties with certain “critical information” about the trial.

The article, “The Effect of Long-Term Disinfection on Clinical Contact Surfaces,” was written by Charles John Palenik, who retired as director of infection control research and services at Indiana University in 2011, according to Medscape Medical News, which first reported the story and whose earlier story had originally flagged issues in the paper to the journal.

The editor of the journal, Michael Glick, initially intended to issue an erratum and explain what went wrong with the article, but not retract the piece, Medscape reported in June.  At the time, Glick told the news service that Continue reading Flawed disclosure leads dental journal to retract disinfection paper